Notice of AGM and posting of Report & Accounts

ImmuPharma PLC (LSE AIM: IMM – Euronext Growth: ALIMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2020, and the Notice of Annual General Meeting has been posted to shareholders.

These documents are available, in electronic form, for download on the Company’s website www.immupharma.co.uk.

ImmuPharma’s Annual General Meeting (AGM) will be held on Monday, 28 June 2021 @ 10.30am (BST) at: 25 Wilton Road, Victoria, London SW1V 1LW.

Government guidance in the UK relating to COVID-19 continues to place restrictions on public gatherings, so shareholders will not be permitted to attend the AGM in person. The AGM will therefore be held with the minimum attendance necessary to form a quorum (which will be facilitated by the Company).

In light of those measures, we strongly encourage you to consider ensuring your vote is counted by submission of the proxy by post. Please complete the paper proxy that accompanies this notice and return it to the Company’s Registrar, Computershare Investor Services plc, The Pavilions, Bridgwater Road, Bristol, BS99 6ZY. All proxy forms must be received by no later than 48 hours prior to the AGM, being 10:30am on Thursday 24 June 2021.

Investor Meet Company | Virtual Participation

In order to ensure that shareholders are able to follow the proceedings of the AGM, the Company will provide a live broadcast of the AGM through the Investor Meet Company (“IMC”) platform. However, shareholders will not be able to vote online during the AGM and are therefore urged to submit their votes via proxy as early as possible. Shareholders are also invited to submit written questions for the Board to consider. Questions can be pre-submitted in advance of the AGM via the IMC platform up to 09:00am on 25 June 2021, being the working day before the AGM, or via the IMC platform at any time during the AGM itself. The Board will respond to key questions during the meeting and will provide such answers via the IMC platform thereafter. Shareholders who wish to attend the AGM online should register for the event in advance via the following link: https://www.investormeetcompany.com/immupharma-plc/register-investor